Last updated on: 10/4/2007 | Author: ProCon.org

David A. Katzenstein, MD Biography

Title:
Associate Medical Director of the Stanford University AIDS Clinical Trial Group
Position:
Pro to the question "Should Marijuana Be a Medical Option?"
Reasoning:

“[I]t is clear that there are people who use marijuana solely to ameliorate symptoms associated with chronic disease, such as HIV/AIDS. This suggests that cannabinoids have potential benefit as a therapeutic class of agents.”

Feb. 2004

Theoretical Expertise Ranking:
     Key Experts
Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
  • Associate Medical Director, Stanford University AIDS Clinical Trial Group, 1997-present
  • Co-Director, Diagnostic Virology Laboratory, Stanford University, 1997-present
  • Associate Professor, Division of Infectious Diseases, Stanford University, 1997-present
  • Recipient, Doris Duke Distinguished Clinical Scientist Award, Affordable Feasible Treatment for HIV infected Women in Southern Africa, 2000
Education:
  • Fellowship, Infectious Diseases, University of California, Davis, 1983
  • Fellowship, Infectious Diseases, University of California, San Diego, 1981
  • Residency, Internal Medicine, University of Davis, 1980
  • Internship, Internal Medicine, University of New Mexico, 1978
  • MD, University of California, San Diego, 1977
  • BA, University of California, San Diego, 1972
Other:
  • None found